Trusted Resources: Education
Scientific literature and patient education texts
Epidemiology and Genetics of Mucopolysaccharidosis Type VI in Russia
source: Frontiers in molecular biosciences
year: 2021
authors: Voskoboeva E,Semyachkina A,Miklyaev O,Gamzatova A,Mikhaylova S,Vashakmadze N,Baydakova G,Omzar O,Pichkur N,Zakharova E,Kutsev S
summary/abstract:Mucopolysaccharidosis VI (MPS VI) is an autosomal recessive lysosomal storage disease caused by mutations in the arylsulfatase B gene () and consequent deficient activity of ARSB, a lysosomal enzyme involved in the glycosaminoglycan (s) (GAGs) metabolism. Here, we present the results of the study of DNA analysis in MPS VI patients in the Russian Federation (RF) and other republics of the Former Soviet Union. In a cohort of 68 patients (57 families) with MPS VI, a total of 28 different pathogenic alleles were found. The most prevalent nucleotide changes included NM_000046.5:c.194C>T and NM_000046.5:c.454C>T. Five pathogenic alleles were novel, not previously reported (NM_000046.5:c.304C>G, NM_000046.5:c.533A>G, NM_000046.5:c.941T>C, NM_000046.5:c.447_456del10, and NM_000046.5:c.990_10003del14). The nucleotide variant NM_000045.6:c.454C>T was the prevalent allele among Slavic Russian patients. The nucleotide variant NM_000045.6:c.194C>T was found only in MPS VI families from the Republic of Dagestan. Based on the analysis of dry blood spots (DBSs) collected from newborns in this RF region, we showed the frequency of this mutant allele in the Republic of Dagestan to be 0.01 corresponding to the MPS VI frequency of nearly 1:10,000, which is one of the highest worldwide. This may eventually make the selective asymptomatic carrier test and newborn screening highly feasible in this region of the country.
organization: Federal State Budgetary Scientific Institution "Research Center for Medical Genetics", Moscow, Russia.DOI: 10.3389/fmolb.2021.780184
read more
Related Content
-
A Multicenter Open-Label Extension Study of Intrathecal Heparan-N-Sulfatase in Patients With Sanfilippo Syndrome Typ...Sanfilippo syndrome type A (mucopolysacc...
-
Molecular Basis of Mucopolysaccharidosis IVA (Morquio a Syndrome): A Review and Classification of GALNS Gene Variant...Mucopolysaccharidosis IVA (MPS IVA, Morq...
-
Clinical Features and Health-Related Quality of Life in Adult Patients With Mucopolysaccharidosis IVA: The Spanish E...Mucopolysaccharidosis (MPS) IVA or Morqu...
-
Production of Therapeutic Iduronate-2-Sulfatase Enzyme With a Novel Single-Stranded RNA Virus VectorThe Sendai virus vector has received a l...
-
MPS IV MorquioWhat is MPS IV?MPS IV, known as Morquio ...
-
Establishing a Core Outcome set for Mucopolysaccharidoses (MPS) in Children: Study Protocol for a Rapid Literature R...Mucopolysaccharidoses (MPS) are a group ...
-
Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities fo...Mucopolysaccharidosis type II (MPS II) r...